MedTrace Logo

Assessment of Eloquent Function in Brain Tumor Patients

NCT01535430 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-01-13

No results posted yet for this study

Summary

Purpose of the study:

AIM 1: Prospectively collect pre-operative \[functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), magnetoencephalography (MEG)\] and intra-operative mapping data in patients with intra-axial brain tumors to assess how well each modality predicts the location of eloquent brain function. In addition, each modality will be compared with the other.

AIM 2: Assess reorganization of eloquent brain function and plasticity in patients with intra-axial brain tumors. This will be accomplished by prospectively collecting post-operative mapping studies and neuropsychological tests to compare them to prior mapping studies as stated above.

Conditions

Interventions

DIAGNOSTIC_TEST

Brain mapping

Brain mapping will be employed pre-, intra-, and post-operatively to evaluate specific functions.

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Michele Aizenberg, MD · University of Nebraska

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2026-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01535430 on ClinicalTrials.gov